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Abstract The human adaptive immune response is known to weaken in advanced
age, resulting in increased severity of pathogen-born illness, poor vaccine efficacy,
and a higher prevalence of cancer in the elderly. Age-related erosion of the T-cell
compartment has been implicated as a likely cause, but the underlying mechanisms
driving this immunosenescence have not been quantitatively modeled and system-
atically analyzed. T-cell receptor diversity, or the extent of pathogen-derived anti-
gen responsiveness of the T-cell pool, is known to diminish with age, but inherent
experimental difficulties preclude accurate analysis on the full organismal level. In
this paper, we formulate a mechanistic mathematical model of T-cell population
dynamics on the immunoclonal subpopulation level, which provides quantitative
estimates of diversity. We define different estimates for diversity that depend on
the individual number of cells in a specific immunoclone. We show that diversity
decreases with age primarily due to diminished thymic output of new T-cells and
the resulting overall loss of small immunoclones.
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1 Introduction
Immunosenescence underlies poor health outcomes in the aging population, includ-
ing diminished vaccine efficacy (Poland et al. 2010; McElhaney and Dutz 2008;
Fleming and Elliot 2008), increased susceptibility to disease (including irregular
presentation, intensified symptoms, longer recovery times, and increased mortal-
ity) (Thomas-Crussels et al. 2012), as well as a heightened risk of cancer (Ginaldi et al.
2001). This degradative aging process of the human immune system originates
from extensive fundamental changes to the size and functionality of immune cell
pools, and the structure of lymphatic tissues in which they develop and oper-
ate (Salam et al. 2013).
Among the many changes associated with immunosenescence (Globerson and Effros
2000), the T-cell compartment is arguably the most damaged (Wick et al. 2000;
Gruver et al. 2007). The T-cell pool is comprised of subpopulations of antigen-
inexperienced naive cells, and antigen-experienced memory cells, the latter of
which retain immunological record of previous infections. The human immune com-
partment maintains∼ 1012 T-cells in total, of which∼ 1011 are naive (Jenkins et al.
2009; Trepel 1974). During aging, the population of naive T-cells declines in over-
all size, while the population of memory T-cells undergoes extensive proliferation,
thereby reversing the balance of naive and memory T-cells that had persisted
at younger ages (Globerson and Effros 2000; Fagnoni et al. 2000). The expan-
sion of memory T-cells further enhances immunological memory of previously-
encountered antigens, reinforcing existent immune protection. The remaining naive
pool experiences loss of T-cell receptor (TCR) “structural diversity” (Goronzy et al.
2007, 2015b)–the number of distinct TCR complexes present across the entire
naive pool. The diversity of T-cell clones, or “immunoclones”, characterized by
the number of distinct TCR complexes among the cell population, provides the
extent of antigen specificity. Unique TCR complexes are generated during T-cell
development in the thymus, via recombination of genes encoding the V and J do-
mains of the TCRα chain and the V, J, and D domains of the TCRβ chain,
along with additional insertion and deletion of nucleotide fragments (Murphy
2012). Combinatorially, a possible Ω0 ∼ 10
15 − 1020 unique TCR complexes
may be assembled via this rearrangement process (Laydon et al. 2015), but only
Ω ∼ (0.05)× Ω0 of those rearrangements are functionally viable (Yates 2014), as
determined by positive and negative selection tests in the thymus, which screen
for appropriate reactivity to self-peptide/MHC molecules. Each TCR is activated
by at least one peptide fragment presented via MHC molecules on the surface
of an antigen-presenting cell, thus loss of naive TCR structural diversity lim-
its the number of new antigens to which the full naive T-cell pool can respond.
Naive cells are also suspected to suffer major functional deficiencies in aging, such
as diminished binding affinity and proliferative capacity after antigenic stimula-
tion (Moro-Garc´ıa et al. 2013). While these effects have been studied mostly using
murine models to date (Appay and Sauce 2014), they are not yet well understood
in humans and are beyond the scope of this paper.
The total abundance of naive T-cells, which inhabit both blood and lymphatic
tissue, can be reliably estimated frommeasurements in small samples (Westermann and Pabst
1990; Bains et al. 2009a). Recently, Westera et al. (2015) estimated an ∼ 52% de-
crease in the naive T-cell population in aging. In contrast, accurate estimation
of full-organism TCR structural diversity is currently impeded by experimental
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imprecision and the inability to extrapolate small sample data to the full organ-
ism (Laydon et al. 2015). Experimentation typically entails DNA sequencing of the
TCRα or–more commonly–β chain, in particular the complimentarity-determining
region 3 (CDR3), which is the site of TCR binding to antigenic peptide and most
significant basis for diversity (Murphy 2012).
Increasingly sophisticated deep sequencing methods have improved estimates
for the lower bound on TCR diversity but direct estimation of TCR diversity
remains a challenge due to various experimental complications, such as the inabil-
ity to detect rare clonotypes, sequencing errors, and inaccurate measurement of
clonotype frequencies resulting from inconsistencies in polymerase chain reaction
(PCR) amplification (Laydon et al. 2015). Predicting full-organism TCR diversity
from a small sample is typically formulated as an “unseen species problem”, and
one of many canonical solutions to such a problem is employed in conjunction
with experimental data (Chao 1984; Chao and Lee 1992; Colwell and Coddington
1994), but the true relationship between sample and full diversity is fundamentally
elusive.
Despite variations across experimental measurements of TCR diversity, its age-
related loss has been consistently observed. An early study conducted by Naylor
et al. (2005) predicted a TCRβ chain diversity of ∼ 2 × 107 that persisted in
donors through age 60, before dropping by two orders of magnitude to ∼ 2× 105
at age 70. More recently, Britanova et al. (2014) collected samples from donors of
all ages and observed an approximately linear decrease in TCRβ CDR3 diversity
from ∼ 7 × 106 in youth (6 − 25 years) to ∼ 2.4× 106 in advanced age (61 − 66
years). Qi et al. (2014) obtained a particularly high lower bound estimate of ∼ 108
unique TCRβ sequences in youth (20− 35 years), which declined two- to five-fold
in advanced age (70− 85 years).
Note that only the TCRβ chain is sequenced in these experiments. Sequencing
of both the α and β chains would potentially produce a more accurate measure of
TCR diversity, but the same experimental limitations preclude complete analysis.
The measurement of diversity is further complicated by the potentially large dis-
parity between structural diversity and “functional diversity”–that is, the number
of antigens to which the T-cell pool is capable of responding. Due to the potential
for crossreactivity, in which one TCR might respond to many structurally similar
peptide fragments, it is possible that actual TCR diversity is much higher than
structural diversity indicates. It has been speculated that one TCR might respond
to as many as 106 different peptide epitopes (Mason 1998).
To obtain lifetime estimates of TCR structural diversity, and develop an in-
formed context for discussion of functional diversity, we introduce a mechanistic
mathematical model of the generation and replenishment of the lymphocyte pool
from birth through the end of life. Although experimental assessments of full-
system information remain challenging, measurements for the dynamics of each
component related to the T-cell population can be found throughout the litera-
ture. Our mathematical approach combines the knowledge of these individual com-
ponents to study their interplay, leading to an understanding of the full-system
dynamics. By extending previous model studies of total cell counts (Mehr et al.
1996, 1997; Ribeiro and Perelson 2007; Bains et al. 2009a, b; Hapuarachchi et al.
2013; Murray et al. 2003; Reynolds et al. 2013), our multi-component formulation
is able to efficiently track the total number of distinct T-cell clones, allowing for a
full-system assessment of TCR structural diversity.
4 Stephanie Lewkiewicz et al.
2 Mathematical Models and Results
We develop our mathematical model by first constructing the equation governing
the total population size of the naive T-cell pool in Sec. 2.1, through which we
quantitatively constrain the primary parameters of our model using experimental
measurements found in previous literature. The model that describes the evolution
of immunoclones is derived in Sec. 2.2, allowing us to define and estimate the
diversity of the T-cell population in Sec. 2.3. In Sec. 2.4, we inspect the impact
of sampling on the estimate of immunoclone diversity, as in practice it is only
possible to extract a small fraction of the entire T-cell population from a body.
2.1 Total T-cell population model
There are three fundamental immunological mechanisms that sustain the naive
T-cell pool: 1) export of mature naive T-cells from the thymus, 2) peripheral
proliferation, and 3) cell removal from the naive pool due to death or phenotypic
changes. These basic mechanisms constitute a birth-death-immigration process
described by the ordinary differential equation,
dN(t)
dt
= γ(t) + pN(t)− µ(N)N(t), (1)
where N(t) denotes the total T-cell count, γ > 0 denotes the rate of thymic
output, p > 0 denotes the rate of proliferation, and µ(N) > 0 denotes the rate of
population-dependent regulated cellular death or loss of naive phenotype.
While more complex feedback mechanisms have been proposed (Mehr et al.
1997), other experiments have shown that thymic export is independent of naive
T-cell counts (Ribeiro and Perelson 2007; Berzins et al. 1998; Metcalf 1963), it is
well-established that the export rate consistently decays throughout the human
lifespan (Murray et al. 2003). The lifelong decline of thymic export is caused by
thymic involution which leads to degradation of structural integrity and functional
capacity of the thymus with age (Steinmann et al. 1985). The age dependence
of the thymic export rate of newly-trained T-cells is often approximated by an
exponentially decaying function, γ(t) = γ0e
−at, where γ0 > 0 is the maximum
rate of thymic output that arises in early years, and a > 0 is the rate of decrease
in thymic output.
The immune systems of vertebrates maintain a healthy amount of naive T-cells
through complex homeostatic mechanisms, which include controlled production
and distribution of common gamma chain cytokines, particularly IL-7, to the naive
pool (Fry and Mackall 2005). IL-7 is secreted by stromal and endothelial cells in
the thymus, bone marrow, and lymphatic tissue, providing T-cells with necessary
survival signals. In lymphoreplete conditions, competition for this limited resource
regulates population size (Bradley et al. 2005; Tan et al. 2001; Vivien et al. 2001),
but in lymphopenic conditions, high levels of IL-7 resulting from low T-cell counts
can even stimulate cellular proliferation. While IL-7 concentration may be ex-
plicitly formulated in a mathematical model of the peripheral T-cell population,
as in the work of Reynolds et al. (2013), most models incorporate IL-7 regu-
lation implicitly in the form of carrying capacity, assuming quick equilibration
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in a state of competition for IL-7 in the presence of a given number of T-cells.
Such simplification commonly leads to the dependence on total cell counts of both
cell proliferation and cell death rates, considering the cytokine’s dual role under
lymphoreplete and lymphopenic conditions described above. Our model assumes
cell-count dependence only of the cell death rate, focusing on scenarios of healthy
aging, i.e., lymphoreplete conditions. We thus assume an N -dependent cell death
rate of the form
µ(N) = µ0 +
µ1N
2
N2 +K2
, (2)
where the first term, µ0 > 0, is the basal rate of cellular death. The second one
describes the IL-7-mediated regulation of cell death, with µ1 > 0 representing the
maximal increase to the death rate as N →∞. The quantity K is analogous to a
“carrying capacity” and dictates the population at which signalling induced death
starts to limit the population. The constant rate of cellular proliferation under
healthy conditions is supported by recent studies of Westera et al. (2015), showing
nearly identical naive proliferation rates at young and old ages during moderate
age-related non-lymphopenic loss of naive cells. IL-7 induced proliferation can
arise in unhealthy lymphopenic conditions typically found in severe disease of the
immune system (Brass et al. 2014), cytotoxic drug use (Gergely 1999), radiation
treatment (Grossman et al. 2015), or other abnormal situations. These scenarios
are, however, beyond the scope of our analysis.
Our model has six adjustable parameters, γ0, a, p, µ0, µ1 and K. The first
four are biologically inherent to the mechanism of T-cell homeostasis, and have
been measured experimentally in humans and rodents. The last two have to be
constrained via parameter sweeps to match relevant experimental observations.
Fig. 1(a) illustrates four qualitatively distinct evolution trajectories of N(t) that
may arise from simulations of the model in the presence of a decaying thymic
export rate γ(t) (gray dash-dotted curve). To non-dimensionalize Eqs. 1, 2, we
use a−1 to rescale t and K to rescale N . The qualitative behavior of our model
is thus controlled by three independent parameters: γ0a
−1K−1, (p− µ0)a
−1, and
µ1 (p− µ0)
−1. The black dashed curve arises when µ1 (p− µ0)
−1 < 1. In this case
cell proliferation always exceeds cell death, leading to unbounded expansion of
the naive T-cell population. This scenario is unrealistic, except perhaps during
a period of lymphopenia. For µ1 (p− µ0)
−1 ≥ 1, cell death is able to balance
cell proliferation at a homeostatic carrying capacity N = Nss(γ = 0), defined by
µ(Nss(γ = 0)) = p, as γ → 0. As illustrated by the green dotted curve, N(t) rises
and asymptotically converges towards Nss(γ = 0) provided that γ0a
−1K−1 ≪ 1.
We refer to this scenario as being in the “proliferation-driven” regime, given
that the cell population is driven to Nss(γ = 0) primarily by homeostatic pro-
liferation. The model’s behavior makes a transition from proliferation-driven to
“thymus-driven” if we increase γ0a
−1K−1. As shown by the blue solid curve,
N(t), driven by increased thymic export, overshoots and approaches Nss(γ = 0)
from above as γ(t) → 0 asymptotically. Finally, the red dash-dotted curve arises
when (p− µ0)a
−1 ≤ 0. In this case cell death always exceeds cell proliferation as
γ(t) → 0, and N(t) → Nss(γ = 0) = 0. As stated earlier, in this paper we fo-
cus on scenarios of healthy aging (lymphoreplete) conditions, which immediately
rules out the scenarios of unbounded growth (black dashed curve) and complete
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collapse of the T-cell population (the red dot-dashed curve), effectively constrain-
ing our parameters to physiologically reasonable values µ1 (p− µ0)
−1 ≥ 1 and
(p− µ0)a
−1 > 0.
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Fig. 1 Qualitative behavior of the total T-cell population model (Eqs. 1,
2). (a) The total T-cell population N(t) as a function of time (in years) for four
qualitatively distinct scenarios. Unbounded growth arises when µ1 (p− µ0)
−1 <
1. and the T-cell population collapses when (p − µ0)a
−1 < 0. Outside of these
two regimes, N(t) converges asymptotically to a positive steady state as γ(t) →
0. If γ0a
−1K−1 ≪ 1, N(t) is driven primarily by homeostatic proliferation and
increases monotonically towards the constant plateau. Increasing γ0a
−1K−1 leads
to a transition from proliferation-driven scenario to thymus-driven populations,
in which N(t) reaches a peak value before converging to the steady state. The
decaying thymic export rate γ(t) is alongside of the N(t) curves as a reference. To
quantify the decrease in cell counts with age, we define N¯y as the average of N(t)
between ages 20 and 30, and N¯o between 70 and 80; then ∆
(
N¯
)
=
(
N¯o − N¯y
)
/N¯y
is the relative change in cell counts. The parameter values used are γ0 = 1.8×10
10,
a = 0.044, andK = 1010 and p = 0.022, µ0 = 0.017, and µ1 = 0.004 for unbounded
growth, p = 0.17, µ0 = 0.18 and µ1 = 0.04 for the collapse scenario, p = 0.18,
µ0 = 0.17, and µ1 = 0.01001 for the homeostasis-driven case, and p = 0.18, µ0 =
0.17, and µ1 = 0.04 for the thymus-driven case. The initial value is N(1) = 10
11
at t = 1 year. (b) ∆
(
N¯
)
as a function of γ0a
−1K−1 and µ1 (p− µ0)
−1. When
γ0a
−1K−1 and µ1 (p− µ0)
−1 are small, N(t) is driven primarily by proliferation
and keeps increasing well into old age, leading to positive∆(N¯) values. Conversely,
for large γ0a
−1K−1 and µ1 (p− µ0)
−1, thymic export dominates and N(t) peaks
at early ages, resulting in negative ∆(N¯). The black dotted curve corresponds to
∆(N¯) = −52% as previously reported by Westera et al. for human adults. At fixed
µ1 (p− µ0)
−1 = 4, we are able to reproduce this curve by setting γ0a
−1K−1 ≃ 41
(corresponding toK = 1010 for our choice of parameter values). The value of∆(N¯)
increases with decreasing γ0a
−1K−1 and become positive when γ0a
−1K−1 . 1.
Here, we fixed (p− µ0)a
−1 = 0.2 and a = 0.044.
We can further quantitatively calibrate the parameter values using experimen-
tal measurements in the literature. The constant peripheral proliferation rate p has
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been measured by Westera et al. (2015) as 0.05% day−1, or equivalently p = 0.18
year−1. The basal death rate µ0 can be estimated from the lifespan of T-cells.
Based on data from Vrisekoop et al. (2008), De Boer and Perelson (2013) obtain
an average naive CD4+ T-cell lifespan of ∼ 5 years and an average naive CD8+
lifespan of ∼ 7.6 years. Given the normal CD4+:CD8+ ratio of 2:1, the average
combined naive T-cell clearance rate is µ0 =
1
5.9 year
−1 = 0.17 year−1. Thymic
involution with age can be quantified by measuring the decrease in thymic epithe-
lial volume (Steinmann 1986), based on which Murray et al. (2003) showed that
thymic output decreases by an average of 4.3% per year between ages 0 and 100,
implying a decay factor of a = | ln(0.957)| ≃ 0.044. The rate of thymic export has
recently been measured for young adults (20−25 years old) at ∼ 1.6×107 trained
cells daily, or equivalently 5.8×109 per year (Westera et al. 2015). Assuming that
this rate is γ(t) at t = 25 years, we can back-calculate γ0 = (5.8× 10
9)×
(
100
33.3
)
≈
1.75 × 1010cell exports/year. Note that these values of p, µ0, and a satisfy the
constraint (p− µ0) a
−1 > 0 that prevents the T-cell population from completely
collapsing.
While direct experimental measurements of µ1 and K are not available in
the literature, further inspection of Fig. 1(a) reveals that µ1 and K determine
whether thymic export or homeostatic proliferation dominates the evolution of
N(t). Through the dimensionless parameters, γ0a
−1K−1 and µ1 (p− µ0)
−1, the
time at which N(t) peaks and how fast it declines from the peak vary with changes
to the values of µ1 and K. Recently, Westera et al. (2015) reported a 52% decrease
in total naive T-cell counts between young human adults and elderly individuals,
which we can use to quantitatively constrain µ1 and K. Let us define individu-
als of an age between t = 20 and 30 years as young adults, and those between
t = 70 and 80 as the elderly. Assuming that interpersonal heterogeneity unre-
lated to age averages out over large sample sizes in clinical data, we may evaluate
N¯y =
1
10
∫ 30
20
N(t)dt and N¯o =
1
10
∫ 80
70
N(t)dt as the average naive T-cell counts
respectively for the young and the elderly, as illustrated by the shaded areas under
the thymus-domination curve in Fig. 1(a). The relative change in the naive T-cell
count between young and elderly adults can thus be evaluated as
∆(N¯) =
(N¯o − N¯y)
N¯y
. (3)
Fig. 1(b) plots ∆(N¯) as a function of γ0a
−1K−1 and µ1 (p− µ0)
−1, with a =
0.044 year−1 for converting the dimensionless time to years to compute N¯y and
N¯o. When γ0a
−1K−1 . 1 and µ1 (p− µ0)
−1 . 2, ∆(N¯) > 0. Note that the home-
ostatic carrying capacity when γ(t) = 0 is Nss(γ = 0) = K
(
µ1(p− µ0)
−1 − 1
)−1
.
A small γ0a
−1K−1 value represents a relatively low thymic export rate, and the
carrying capacity increases rapidly as µ1 (p− µ0)
−1 → 1, both of which make it
challenging for thymic output to fill up the T-cell pool to carrying capacity before
γ(t) considerably decays within t ∼ a−1. As a result, N(t) does not reach a peak
value at a young age and continues increasing into old age. The ≈ 52% decrease
in naive T-cell counts reported by Westera et al. (2015) is depicted by the black
dotted curve. If we set µ1 (p− µ0)
−1 = 4, our model can be calibrated to repro-
duce this decrease in the cell count by choosing K = 1010 (γ0a
−1K−1 ≃ 41 with
γ0 = 1.8 × 10
10 and a = 0.044). In contrast, K = 1012 yields γ0a
−1K−1 ≃ 0.41,
leading to an increase in the cell count (∆(N¯) ≃ 0.63). In between, K = 1011
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results in a moderate decrease in the cell count (∆(N¯) ≃ −0.33). For the rest of
the paper, we fix K = 1010 and µ1 (p− µ0)
−1 = 4, or equivalently µ1 = 0.04 given
that p = 0.18 and µ0 = 0.17, so that the age-related decline of N(t) in our model
is consistent with Westera et al. (2015).
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Fig. 2 Comparison of Thymic Export and Cell-Population Evolution
Time Scales. (a) Plots of N(t) and Nss show discrepancy. The γ(t)-dependence
makes Nss decline monotonically with the exponentially decaying thymic export,
and Nss approaches a small positive value as γ(t)→ 0. The solution N(t) evolves
towards Nss but never catches up with it because of a slower evolution time scale.
(b) Comparison of timescales of thymic atrophy and cell-population evolution.
Thymic atrophy is the faster mechanism for most choices of the system’s param-
eters. Increasing µ1 shortens the time scale of clone evolution, indicating that
the steady state solution can be a reasonable approximation to the fully time-
dependent solution at very large µ1 and very small p − µ0. Here, varying Nss
within the range [1010, 1012] yields almost identical results, and the values of γ0
and K, chosen within the reasonable parameter regime, do not affect the results
significantly. Parameter values used are γ0 = 1.8 × 10
10, a = 0.044, p = 0.18,
µ0 = 0.17, K = 10
10, Ω = 1016. For (a) µ1 = 0.04, and the initial condition is
N(1) = 1011.
Note that there exist two intrinsic timescales in Eq. 1; thymic export decays at
a rate a, while the homeostatic time scale is controlled by p, µ0, and µ1. If home-
ostasis is much faster than thymic involution, the solution of N(t) will quickly
converge to the quasisteady state solution as γ(t) evolves. We compare these two
solutions in Fig. 2(a), where the quasisteady-state solution is obtained by solv-
ing for the steady-state solution Nss of Eq. 1 with fixed γ(t) at each time t, and
Nss(γ(t)) (black dashed curve) decreases monotonically with age due to the contin-
uous decline of γ(t). In contrast,N(t) (blue solid curve) slowly rises from the initial
conditions N(1) = 1011 and does not approach the quasisteady-state level until
age ≈ 20 years. The trajectory of N(t) then overshoots the declining Nss(γ(t)),
reaches a peak value, and reverts course to go after Nss(γ(t)). However,N(t) never
catches up with Nss(γ(t)) before the latter reaches a steady state of very low cell
counts. That N(t) keeps lagging behind Nss(γ(t)) indicates that the timescale for
the full model solution to converge to the steady state is slower than the evolution
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of the nonautonomous term γ(t). The results here suggest that steady-state solu-
tions cannot adequately describe the temporal evolution of the T-cell population
in the biologically relevant range of parameter values that we have implemented.
It is necessary to numerically compute the time-dependent solutions for the full
nonautonomous equation.
Indeed, we find a disparity in the rates at which thymic export decays and
the steady state solutions evolve. The latter is provided by the inverse of the
eigenvalue of Eq. 1 linearized around N = Nss(γ(t)). The eigenvalue takes the
form λ1 = p0− (µ0+µ1((3N
2
ssK
2+N4ss)/((K
2+N2ss)
2)). Simulations in Fig. 2(b)
show that for the biologically relevant parameter values we have implemented, the
cell-population evolution timescale, |λ1|
−1 (red solid curve), is generally longer
than the timescale of thymic involution (a−1 ≃ 22.7 years for a = 0.044 as denoted
by the horizontal black dotted line). Hence the nonautonomous solutions N(t) are
expected to lag behind the thymus-driven steady-state solutions Nss. For N(t) to
be reasonably approximated by Nss, the cell population has to evolve much faster
than thymic involution, corresponding to the regime of very large µ1, as indicated
by the blue dash-dotted curve, where cell death is extremely sensitive to the cell
population size.
2.2 Clonotype Abundance Distributions
Quantification of the populations of individual clonotypes would require analysis
of models that track the population dynamics of naive T-cells of each TCR type.
Assuming the same population dynamics for each T-cell clonotype i, which may
be appropriate for certain scenarios, the evolution of the expected cell count ni(t)
may be deduced from Eq. 1 and take the following generalized form,
dni
dt
=
γ(t)
Ω
+ pni − µ(N)ni, (4)
where γ(t)/Ω represents thymic export of naive T-cells of each clonotype (the
total thymic export rate normalized by the total number of viable TCR combina-
tions Ω), and N(t) =
∑
i ni(t). Within the framework of these “neutral” models,
basic qualitative behaviors of T-cell population dynamics have been investigated,
particularly for scale-invariant properties that can be studied in a reduced sys-
tem (Lythe et al. 2016; Desponds et al. 2015). Indeed, the total numbers of T-cell
clonotypes Ω in rodent or human bodies are prohibitively large for direct numer-
ical simulations of the full system using Eq. 4. It is thus common to reduce the
full system to a more manageable size with the assumption that the phenomena
under investigation are scale-invariant. However, it is sometimes difficult to assert
whether a certain property really does not change in a re-scaled system, as non-
linear phenomena, such as the Allee effects, often arise in population dynamics
and cast doubt on the scalability of the system. Moreover, some properties, such
as the thymic export rate γ(t), are naturally scale dependent. It is not always
clear how these quantities should be re-scaled in a reduced system, and they have
usually been omitted by simplification arguments in previous models, which limits
the applicability of these models.
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In particular, thymic involution is known to be associated with the age-related
loss of T-cell diversity. Without the explicit inclusion of the thymic export rate,
such loss of T-cell diversity cannot be properly investigated. To facilitate a more
manageable full-system model, we consider a formulation that tracks how the
expected number of clones of a given size changes with time. By focusing on clone
count rather than the explicit cell count of each distinct clonotype, we are able to
effectively reduce the number of tracked variables and thus the dimension of the
model. This representation was used by Ewens in population genetics (1972), by
Goyal et al. (2015) in the context of hematopoietic stem cell population dynamics,
and by Desponds et al. in the context of T-cells (2017). We define cˆk(t) to be the
number of clones represented by exactly k naive T-cells in the organism at time t:
cˆk(t) =
Ω∑
i=1
δni(t),k, (5)
where the Kronecker delta function δx,y = 1 when x = y and 0 otherwise. By
lumping clonotypes of the same cell count into one single variable cˆk, this alterna-
tive formulation can efficiently describe changes to the TCR clone diversity in the
full system, albeit at the expense of the ability to distinguish each specific clono-
type (Morris et al. 2014; Mora and Walczak 2016). Individual clone information
is lost, and ni(t) cannot be recovered from cˆk(t) after the transformation in Eq. 5.
Nonetheless, the amount of computation can be significantly reduced by truncat-
ing cˆk(t) at a reasonably large k, as few large clones exist in realistic scenarios, and
cˆk(t) for large k is negligible. Letting c0(t) ≡ 〈cˆ0(t)〉 denote the expected number
of all possible (thymus-allowed) clonotypes unrepresented in the periphery at time
t, and ck(t) ≡ 〈cˆk(t)〉 the expected number of clones of size k at time t, a closed
set of equations governing the evolution of ck(t) can be derived from Eq. 4 in the
mean-field limit,
dck(t)
dt
=
γ(t)
Ω
[ck−1 − ck] + p [(k − 1)ck−1 − kck] + µ(N) [(k + 1)ck+1 − kck] ,
(6)
where N(t) =
∑∞
i ni(t) =
∑∞
ℓ=1 ℓcℓ(t). The expected values ck(t) are also called
species abundances in the ecology literature. The number of unrepresented clones
is c0 = Ω−
∑∞
k=1 ck, and summing Eq. 6 multiplied by k over k = 1, 2, · · · recovers
Eq. 1. The mean-field assumption is articulated in terms such as µ(
∑
ℓ ℓcˆℓ)cˆk that
involve higher-order products of cˆk rather than correlations of products of cˆk.
We have found (unpublished) that this mean-field approximation breaks down
only when γ/µ < 1/Ω ≪ 1 for which the total population is proliferation driven
and the quasistatic configuration is N ∼ K and all ck ∼ 0 except cN . Thus, we
reasonably assume that γ(t) > µ/Ω allowing the use of the mean-field equations
6.
In Eq. 6, the terms in the forms of (γ(t)/Ω)ck, pkck, and µ(N)kck respectively
represent the effect of thymic export, homeostatic proliferation and cell death
on a T-cell clone already represented by k cells in the peripheral blood. Adding
one cell via thymic export or homeostatic proliferation moves one clone from the
ck-compartment to the ck+1-compartment, while the death of one cell shifts one
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clone from the ck-compartment to the ck−1-compartment. We approximate the
proliferation rate p as a constant, at which rate all cells of all clones of size k
replicate via homeostatic proliferation. Proliferation reduces ck and increases ck+1.
Terms of the form µ(N)kck, where the IL-7 regulated death rate µ(N) is given by
Eq. 2, reduce ck and increase ck−1.
For a healthy aging adult, the TCR repertoire is mostly comprised of small
clones with the probability of finding large clones decreasing with clone size k.
To numerically solve Eq. 6, we thus truncate the model at a maximum clone size
M ≫ 1, beyond which the probability of finding a clone is assumed negligible.
For our implementation of the truncation, please see Appendix A. In Fig. 3(a) we
examine the effect of the truncation clone size M , showing sufficient convergence
of c10 at t = 40 and 70 to fixed values when M & 30, which indicates that further
inclusion of clones beyond c30 has little effects on the solution for t . 70 years. For
numerical simulations of Eq. 6 in this paper, we set M = 200 to ensure minimal
truncation errors.
M
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Fig. 3 Simulations of Eq. 6. (a) Effect of numerical truncation. We plot c10(40)
and c10(70) as functions ofM for 10 ≤M ≤ 100. Compartment sizes are effectively
fixed when M & 30. (b) Temporal evolution of ck(t). We plot c2(t), c19(t), and
c59(t). Each ck(t) curve rises to a peak value and subsequently decreases. As k
increases, ck(t) decreases in magnitude, and the time at which it reaches the peak
value is pushed back. Parameter values: γ0 = 1.8 × 10
10, a = 0.044, p = 0.18,
µ0 = 0.17, µ1 = 0.04, K = 10
10, Ω = 1016. Initial values c1(1) = 10
11, c0(1) =
Ω − 1011, ck(1) = 0 for all k ≥ 2
Fig. 3(b) shows the temporal evolution of ck(t) for k = 2, 19, and 59. As k
increases, the overall magnitude of the ck(t) curve decreases, and the age at which
ck(t) peaks increases. For example, c2(t) peaks around t . 20 years, and there
are many fewer clones of exactly two copies at old ages than at young ages. In
contrast, c19(t) peaks around age 55, and the numbers of clones that have exactly
19 copies are roughly the same between old and young ages, whereas the number
of clones that have exactly 59 copies (c59(t)) keeps increasing into old ages.
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The relatively earlier decline of ck(t) with smaller k is expected, considering
that rare clones are introduced into the peripheral circulation primarily by the
thymus, which started to involute after birth. With increasing k, the influence of
thymic export on ck(t) decreases, whereas the dependence on homeostatic prolif-
eration increases. Recalling that the rate of thymic involution is faster than the
time scale for homeostasis to drive the clonal population towards equilibrium, the
fast decline of the rare clone population leaves room for larger clones to expand.
To accompany the steady stateNss, we compute analogous fixed-γ0 steady state
values of the full system, cssk , in Appendix B. The steady states satisfy c
ss
k → 0 as
γ0 → 0 for all 1 ≤ k ≤M . We further show that in spite of the fact that c
ss
k → 0,
Eq. 6 asymptotically yields a positive total cell count N = limM→∞
∑M
k=1 kc
ss
k > 0
asM →∞, qualitatively consistent with Eq. 1. Moreover, we prove in Appendix C
that solutions ck(t) of the full nonautonomous system satisfy ck(t) → 0 for all
k ≤M , with arbitrarily largeM , as t→∞. This result is completely independent
of the assumed functional forms of the proliferation and death rates, suggesting
that manipulation of homeostatic regulatory mechanisms cannot prevent the ex-
tinction of small T-cell clones caused by decaying γ(t). We thus conclude that
thymic involution dictates the age-related decline of the TCR diversity of the
naive compartment.
2.3 Diversity of the Naive T-cell Repertoire
By computing the functions ck that track the number of clones consisting of k cells,
we should have sufficient information to evaluate the variation in TCR structural
diversity over a lifetime. Expected TCR structural diversity or “richness” is the
total number of distinct clones present in the immune compartment, for which we
define a threshold TCR richness diversity,
Rq(t) =
∑
k≥q
ck(t), (7)
where q ∈ N is a lower threshold, so that the quantityRq(t) represents the number
of clones of size at least q present in the immune compartment at time t. Situations
in which such a q-dependent threshold arise may include consideration of immune
surveillance, in which small clones may evade detection.
As shown in Fig. 4(a), Rq(t) increases at young ages, peaks at a mature age,
and declines afterwards. For our previous parameter values, the peak age of R1(t)
is approximately t ∼ 16. Higher q lead to older peak ages of Rq(t), consistent with
the results in Fig. 3(b), in which the number of larger clones peaks at older ages.
To compare Rq(t) between the elderly and young, we adopt the same criterion
as with total cell counts and compute window-averaged values of Rq(t) between
ages 20 and 30 for the young and between ages 70 and 80 for the elderly. By
defining R¯y(q) ≡
1
10
∫ 30
20
Rq(t)dt, R¯o(q) ≡
1
10
∫ 80
70
Rq(t)dt, we quantify the loss of
richness by computing its relative change.
∆(R¯q) ≡
(R¯o(q)− R¯y(q))
R¯y(q)
. (8)
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Fig. 4 Simulation of Threshold Richness Diversity. (a) Rq(t) as a function
of t, for q = 1, 2, 3. Rq peaks at later times as q increases. (b) ∆(R¯q(t)) for varying
q, µ1. Higher µ1 correspond to more severe loss of T-cell clones in advanced age.
(c) ∆(R¯q) for varying q, K. Small values of q result in a lifetime decrease to Rq,
but larger values result in a lifetime increase. This is due to the fact that Rq
peaks at later times as q increases. (d) ∆(R¯1) for varying µ1, K. Initial values
c0(1) = Ω − 10
11, c1(1) = 10
11 ck(1) = 0 for k ≥ 2. Parameter values, when
not varying: Ω = 1016, K = 1010, p0 = 0.18, µ0 = 0.17, µ1 = 0.04, a = 0.044,
γ0 = 1.8× 10
10.
Using the same parameter values as in Fig. 4(a), we plot ∆(R¯q) with respect
to µ1 and q in Fig. 4 (b),(c). In Fig. 4(b), ∆(R¯q) decreases monotonically with
increasing µ1, suggesting that upregulated death rate exacerbates the age-related
loss of richness, and the impact is more significant for larger q. Fig. 4(c) shows that
when K = 1010, ∆(R¯q) < 0 for q ≤ 4. This decreasing trend of Rq generally agrees
with the loss of diversity observed in recent experiments where measurements were
available across multiple ages (Qi et al. 2014; Britanova et al. 2014). For q = 5, 6,
∆(R¯q) ≈ 0, and Rq is nearly unchanged between youth and advanced age. For
q ≥ 7, ∆(R¯q) > 0, indicating higher Rq at older ages. Generally, the lifetime
decrease in Rq(t) occurs with small q, whereas for large q, the trend is reversed, in
agreement with our discussion of Fig. 3(b) and Fig. 4(a) regarding peak ages. This
phenomenon indicates that loss of diversity is primarily due to the extinction of
rare clones, which is consistent with the observation made by Naylor et al. (2005).
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In contrast, the number of larger clones increases over time, leading to the lifetime
increase to Rq(t) at higher q.
Recent TCR-β sequencing studies have attempted to estimate the change in
the repertoire richness of the naive T-cells with age. Despite the difference in
orders of magnitude regarding the total number of circulated naive T-cell clones,
these studies agreed quantitatively in the ratio of the age-related loss of richness.
For example, Britanova et al. (2014) estimated ∼ 7 × 106 clonotypes in youth
(ages 6− 25), and ∼ 2.4× 106 in aged individuals (ages 61− 66), a roughly 66%
drop from the youth figure. Similar measurements were also reported by Qi et
al. (2014), in which a two-to-five-fold decline (i.e., a 50% – 80% drop) between
youth (ages 20− 35) and advanced age (ages 70− 84) was observed. These results
are quantitatively consistent with our computation of∆(R¯1) forK = 10
10 – 1011.5
and 0.03 ≤ µ1 ≤ 0.05 in Fig. 4(d), whereas the decline of Rq for q ≥ 2 is not as
pronounced as in these experimental observations.
Also note that the loss of clonal richness is more severe than the decrease
in the total cell count between young and aged individuals. In Fig. 4(a) ∆(R¯1)
changes between ∼ −66% and ∼ −76% for 0.03 ≤ µ1 ≤ 0.05 and K = 10
10. In
contrast, Fig. 1(b) shows that for the same parameter range, ∆(N¯) varies from
∼ −30% to ∼ −62%. However, the figures also reveal that richness is relatively less
sensitive to changes to the cellular death rate, compared to the total cell count.
This outcome reflects the fact that homeostatic cellular death is uniformly random
across the entire naive T-cell population. The drop in richness is due to cell death
within small clones that drives these clones to extinction, as observed by Naylor
et al. (2005). Increases to the cellular death rate do not cause as much additional
clonal extinction as they do additional cellular extinction, as many surviving clones
are too large to wipe out by the death of a few cells.
2.4 Sampling Statistics
Considering that naive T-cell richness is often assessed via small blood samples,
let us next use the same framework to examine the relation between the detected
clone sizes in small samples and the true clone sizes in the full organism. As
before, denote by N the total number of naive T-cells in the human’s immune
compartment, and Y ≤ N the number of cells collected during sampling from
among the N total. We assume that the N total cells consist of R distinct clones,
which we number from 1 to R. In this section, we denote by cNk the mean number
of clones of size k from among the N total cells in the full organism (denoted by
ck in the previous simulations), and by c
Y
k the mean number of clones of size k in
the sampling of Y cells taken from the N total cells. Then the expectation of cYk ,
denoted by E[cYk ], is,
E[cYk ] =
R∑
j=1
jP
(
cYk = j
)
, (9)
where P
(
cYk = j
)
represents the probability that there are precisely j clones of
size k in the sampling. Then E[cYk ] may be expressed explicitly in terms of the c
N
k
as:
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E[cYk ] =
R∑
l=k
1(
N
Y
) cNl
(
l
k
)(
N − l
Y − k
)
. (10)
(See Appendix D for the detailed proof.) The collection of expressions given by
Eq. 10 for k = 1, 2, · · · , R, yields a linear system of equations solvable for cNk ,
using sampled data for the quantities E[cYk ]. More specifically, if we define the
vectors Ê := (E[cY1 ],E[c
Y
2 ], · · · ,E[c
Y
R ], ) and E := (c
N
1 , c
N
2 , · · · , c
N
R ), Eq. 10 can be
written as Ê = AE, where A is a constant matrix that has non-zero elements only
in the upper triangle, with non-zero diagonal entry 1
(NY )
(
N−k
Y−k
)
in position (k, k).
The equation can always be solved uniquely for E given Ê. Thus the full size
distribution E can be uniquely reconstructed from the expected mean sample size
distribution Ê measured experimentally, provided that the latter can be reliably
estimated through a sufficient number of repeated samplings.
In Fig. 5(a), we use Eq. 10 to compute E[cYk ] from simulated c
N
k , comparing
the predicted sampling results for varying choices of Y . The results indicate that
each decrease by one order of magnitude to the sample size results in a decrease
by roughly the same order of magnitude to the predicted diversity. Thus, diversity
predictions vary with sample size, and small samples do not result in accurate
measurements of diversity.
In Fig. 5(b) we examine how sampling may affect the diagnosis of the age-
related TCR richness decline ∆
(
R¯q
)
defined in the previous subsection. We find
∆
(
R¯q
)
, which is negative, increasing with decreasing sampling fraction f , reveal-
ing that sampling causes an underestimate of the richness decline. As previously
discussed, the decline of TCR richness at old ages is primarily due to the extinc-
tion of small clones. Since small clones often evade detection during sampling,
their extinction is largely unaccounted for, leading to lessened reduction of the
richness measure. When f is very small, most of the small clones have escaped
detection; thus decreasing f further does not change ∆
(
R¯q
)
. Moreover, we note
that ∆
(
R¯1
)
, which is the most straightforward measure for age-related loss of
TCR richness, changes from −73% for the full sample, to −59% for a sampling
fraction f ≤ 10−3, which is close to the value of ∆
(
R¯3
)
for the full sample. This
reaffirms our discussion in the previous subsection that a threshold q > 1 may
arise during the process of sampling. The results here indicate that when only a
small fraction of a T-cell population is used to measure ∆
(
R¯1
)
, clones fewer then
three copies largely evade detection, yielding a result equivalent to ∆
(
R¯3
)
of the
full sample, which underestimates the actual decrease of the TCR richness.
3 Discussion
We have formulated a model of lifetime human naive T-cell population dynamics,
which traces T-cell lineages on the level of individual clones. It accounts for expo-
nentially decaying lifetime thymic export, a constant rate of cellular proliferation,
and variable cellular death rate that adjusts to present cell counts and availability
of survival resources. It depicts the generation of the naive T-cell pool in early life
via thymic export, and long-term maintenance of the population via peripheral
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Fig. 5 Comparison of Actual and Sampled Richness. (a) True lifetime R1,
as well as the expected R1 that result from extracting 10%, 1%, and 0.1% of the
total cell count for sampling. (Y = f × N , with f = 10−1, 10−2, 10−3.) Each
decrease to the sample size by one order of magnitude results in a decrease to the
expected R1 by approximately one order of magnitude. (b) The ratio of age-related
TCR richness decline ∆
(
R¯q
)
as a function of sampling fraction f for clone size
thresholds q = 1 – 5. As f decreases, the value of ∆
(
R¯q
)
increases, indicating a
lower estimate of the TCR richness decline. When f is very small,∆
(
R¯q
)
becomes
insensitive to further decreases to f . Parameter values used: γ0 = 1.8 × 10
10,
a = 0.044, p = 0.18, µ0 = 0.17, K0 = 10
10, Ω = 1016, µ1 = 0.04. Initial values
c0(0) = Ω, ck(0) = 0 for k ≥ 1
turnover after thymic export has waned. Values of most of the model’s parameters
can be found in previous literature, while the few exceptions are obtained by fitting
some basic results of the model, such as age-related T-cell loss, to previous experi-
ments. Our analysis serves two important purposes: to map the thymic machinery,
identifying which components do and do not contribute to age-related cellular loss,
and then to interpret the nuanced role of that cellular loss in immunosenescence.
First, we have found that if thymic export is assumed to decay exponentially
to zero, then all compartments ck(t) (with 1 ≤ k ≤ M) deplete as t → ∞, inde-
pendent of essentially any restrictive assumptions about the homeostatic prolifer-
ative mechanism in the periphery. Concretely, for any choice of proliferation and
death rates p(N), µ(N), that satisfy p(0), µ(0) > 0 and the choice γ(t) = γ0e
−at
with γ0, a > 0, there exists a sufficiently small δ > 0 guaranteeing ck(t) → 0 as
t → ∞ for all 1 ≤ k ≤ M , provided that
∑
|ck(1)| ≤ δ. Although this result
only guarantees that trajectories ck(t) started sufficiently close to zero converge
to zero, simulation indicates that the basin of attraction to this “zero state” is
actually quite large. In fact, for the typical initial conditions used throughout this
paper, simulation suggests convergence of all compartments ck to zero in infinite
time. Although it takes an extremely long time to deplete all ck compartments for
1 ≤ k ≤M , the initial phase of this process can still cause significant loss of T-cell
diversity in aging individuals within a human lifespan. Most importantly, we find
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that the T-cell loss driven by exponentially-diminishing thymic export alone is
robust against any assumptions about the homeostatic proliferative mechanism in
the periphery, as this outcome is universal for all functional forms of p(N), µ(N);
even a particularly strong homeostatic mechanism (say, one with p(0) ≫ µ(0))
cannot rescue a plunging diversity. This, in turn, suggests that in searching for
treatments of age-induced loss of diversity, efforts should be directed at the thy-
mus, in particular to maintaining thymic productivity into advanced age.
Moreover, we compare the real-time simulations and the quasisteady-state so-
lutions of the total cell count, as well as the number of distinct clones, over the
course of age-related thymic output erosion. We find that our simulation results
keep lagging behind the quasi steady state solutions, suggesting that the erosion
time scale of thymic output is faster than the time scale for the population dy-
namics to relax towards a steady state. Mathematically, this result reveals that the
evolution of the T-cell population within the human lifespan is a rather dynamical
phenomenon, which may not be well-described by quasistatic solutions, requiring
evaluation of the fully nonautonomous system. Biologically, our results indicate
that the loss of T-cell diversity is a delayed response to thymic involution, and
assessment of thymic function may predict the health of the immune system.
Although peripheral division cannot salvage the T-cell population on a long
time scale, higher basal proliferation rates may at least delay the erosion of the T-
cell compartment, sustaining acceptable effectiveness of the immune system within
the human lifespan (Naylor et al. 2005). We assumed a constant lifetime rate of
cellular proliferation, but alternative research suggests that proliferation rates may
increase with age (Naylor et al. 2005). In light of this finding, we briefly inspect
the effect of increased proliferation rates at advanced ages on cellular and clonal
loss by modifying p(N) and µ(N) in Eq. 6. For simplicity, we take the death
rate to be constant (µ(N) = µ0 > 0), and adopt a logistic growth rate, p(N, t) =
p(t)(1−N/K), where a discrete increase in the proliferation rate is incorporated in
p(t) = p0(1+rH(t−T )), with p0 > 0 the early-life basal cellular proliferation rate,
and H(t) the Heaviside function, with T the age at which the rate increases. The
constant r specifies the increase to the proliferation rate. (Full simulation details
are given in the caption of Fig. 6.) By varying r, simulation under these alternate
hypotheses indicates that increased basal proliferation rates do lead to notably
higher total cell counts (Fig. 6(a)), but have little effect on diversity (Fig. 6(b)).
These results further affirm that expansion of peripheral proliferation is unlikely
to rescue the eroding naive T-cell diversity, despite the increased cell count. If
diversity loss is the main cause of immunosenescence (still a debatable topic in
the medical community), peripheral proliferation may not be the sensible target
of treatments.
The increased N(70) and nearly unchanged R1(70) in Fig. 6 imply that the
decline of T-cell diversity at old age may appear more dramatic if the diversity
is measured in terms of frequency of distinct TCR sequences among the cycling
cells, which corroborates the explanation that an increase of proliferation rate at
old age leads to a sharp decrease of T-cell diversity (Naylor et al. 2005). Previous
models have shown that even sharper decline of T-cell diversity can be induced by
fitness selection, where certain clonotypes increase their fitness at old age possibly
due to higher avidity to self-antigens (Johnson et al. 2012, 2014; Goronzy et al.
2015a).
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Although the boosts to the total cell count through artificial expansion of the
proliferative mechanism are unable to replenish the declining TCR diversity in the
naive T-cell pool, it is possible that the impact is less severe than the decaying
richness would have indicated, considering that most of the extinct clones are
originally small clones, which may be much less effective than larger clones. In
this regard, the viability of treating immunosenescence by expanding peripheral
proliferation depends on the elucidation of the T-cell pool’s effectiveness clone
size–that is, the size a clone must have attained to effectively guarantee activation
of the clone when its cognate antigen infiltrates the organism. The effectiveness
clone size is intrinsically linked to true functional TCR diversity; if we can identify
a threshold integer q∗, such that clones of size at least q∗ are reliably activated
in the presence of their cognate antigen(s), but that smaller clones are not, then
Rq∗(t) is naturally the most useful measure of diversity, because it accounts for
precisely those clones actively participating in the adaptive immune mechanism.
The larger the “correct” choice of q∗ is, the more effective treatments to boost
cellular proliferation in the periphery will be. Our model directly yields the number
of clones of a particular size, making it straightforward to include or exclude clones
below a certain cell count, should such a threshold exist and be identified.
The effective clone size is also significant to the question of whether diversity
loss is the driving factor in immunosenescence. Using the parameter values that we
found in the literature,Rq(t) decreases for q ≤ 4 from youth to advanced age, stays
nearly constant for q = 5, 6, and increases for q ≥ 7. The extinction of small clones
allows the surviving clones to expand in size, leading the richness of large clones to
increase at old ages. If the minimal size for a T-cell clone to effectively respond to
antigens is large, the diversity of such “effective” clones may actually increase with
age, strengthening the immune response. Therefore, either the minimal clone size
required for effective immune response is low, or the weakened immune response
at old ages is caused primarily by other mechanisms. For example, functional defi-
ciencies acquired by naive T-cells in aging are one possible alternative cause of the
weakened immune response. Such functional deficiencies have been studied heav-
ily in mouse models, but research in humans is still lacking (Appay and Sauce
2014). Diminished naive T-cell effector responsiveness and proliferative capacity
have been observed in aged mice (Moro-Garc´ıa et al. 2013). It is possible that
similar changes occur in humans. Conversely, experiments on mice have directly
shown that loss of TCR diversity does have an actively detrimental effect on im-
mune responsiveness (Yagger et al. 2008), supporting the notion that loss of TCR
diversity as a significant contributor to immunosenescence.
Our model illustrates the feasibility of several different scenarios, in which loss
of diversity contributes to immunosenescence on drastically different levels. There
is clearly a strong need to investigate the effects of both age-related structural
diversity loss and T-cell functionality loss in human subjects in vivo, to better
understand the causes of immunosenescence. Moreover, our model indicates that
the effectiveness clone size and crossreactivity in vivo are valuable pieces of missing
information, the elucidation of which would allow for the identification of effective
options to treat immunosenescence.
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Fig. 6 Total Cell Count and Richness with Rise in Proliferation. Simu-
lation of Eq. 6 with exponentially decaying thymic export, and peripheral home-
ostasis described by time-varying logistic growth. We use the thymic export rate
γ(t) = γ0e
−at, peripheral death rate µ(N) = µ0 > 0, and peripheral proliferation
rate p(N, t) = p(t)(1− (N/K)), with p(t) = p0(1 + rH(t− T )). Here, H(t) repre-
sents the Heaviside function with jump at t = 0. The constant r determines the
magnitude of the increase to the basal proliferation rate, and T represents the time
at which the jump occurs. We take the jump to occur at varying ages. (a) ∆(N¯)
with jump at ages T = 30 and 70, for varying r. (Curve corresponding to T = 50
is omitted due to close similarity to T = 30 curve.) Raising the basal proliferation
rate diminishes cellular loss in advanced age, with sufficiently high values of r pro-
ducing a lifetime increase in total cell counts. The positive steady state solution
of the autonomous total cell ODE, dN/dt = γ0 + p0(1−N/K)− µ0N , is given by
N∗ = (K/2)(1− µ0/p0 +
√
(1− µ0/p0)2 + 4γ0/Kp0), and can be seen to satisfy
∂N∗/∂p0 > 0 if γ0 < Kµ0, suggesting that increases to the basal proliferation
rate are likely to increase the total cell count. (b) ∆(R¯1) with T = 30, 50, and 70,
for varying r. Increases to the basal proliferation rate do mitigate diversity loss,
but the effect is minor and potentially insignificant. Increases to the basal prolif-
eration rate increase ck+1 due to a decrease in ck, preserving additional diversity,
but the lifetime diversity loss is still observed, even when proliferation rates are
high enough to generate a lifetime increase to the total cell count. Fixed param-
eter values: γ0 = 1.8 × 10
10, a = 0.044, p0 = 0.18, µ0 = 0.17, K0 = 3 × 10
11,
Ω = 1016. Initial values: c0(1) = Ω− 10
11, c1(1) = 10
11 ck(1) = 0 for k ≥ 1. Eq. 6
is truncated at k = 200.
4 Summary and Conclusions
We have simulated the time evolution of the functions ck(t), which represent the
number of naive T-cell clones of size k present in a human’s immune compartment
at time t. We determined that under essentially any realistic assumptions about
homeostatic proliferation and death, all clones deplete in infinite time if thymic
export is assumed to decay exponentially. This implicates thymic export as a fun-
damental cause of age-associated diversity loss. We simulated our model under the
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assumption that a carrying capacity is regulated by homeostatic proliferation and
death through N -dependent rates. We found that the manipulation of homeostatic
proliferation and death rates, which may notably raise the carrying capacity and
thus the total cell count, was unable to save falling diversity as an individual ages.
It affirms the vital role of thymic output in age-related diversity loss, and indicates
that boosting the proliferation rate is unlikely an effective solution. However, if
only clones of large size are sufficiently effective in the immune response, boosting
proliferation rates might raise average clone sizes and help to mitigate the effects
of lost diversity. We simulated “threshold richness diversity”, Rq(t), which counts
the total number of clones of size q or larger. We found that by increasing q, the
trajectory of Rq(t) changes from decreasing to increasing over a human lifetime.
From this trend, we concluded that if only large clones are effective, the effec-
tive richness would actually increase with age, suggesting that it is important to
identify the minimal effective clone size in order to determine whether the loss of
TCR diversity is the primary driving mechanism of the immune dysfunction seen
in advanced age. Lastly, we derived a one-to-one mapping between the full-sample
diversity cNk of N cells and the expected measurement of diversity E[c
Y
k ] in sam-
ples of Y cells. We found that the probability of detecting small clones shrank
significantly with small sample sizes, which could potentially skew small-sample
statistics. In particular, we show that small samples tend to underestimate the
age-related loss of T-cell richness diversity. Our formulation provides a rigorous
method for accurately inferring the statistical distribution of clonal sizes from
small-sample measurements.
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A Implementation of Numerical Truncation
The most straightforward way to truncate Eq. 6 at k = M is to neglect the exchange terms
between cM and cM+1, assuming a negligible contribution for k > M and essentially imposing
a “no-flux” boundary condition. This leads to the following equation for the boundary term
cM (t):
dcM (t)
dt
=
γ(t)
Ω
cM−1 + p(M − 1)cM−1 − µ(N)McM . (11)
This formulation, however, introduces a truncation error in Eq. 1 if we define N =
∑M
k=1 kck.
The neglected terms leave a small loss of total cell count in dN/dt. An alternative implemen-
tation of the truncation is adding these small loss terms to the boundary equation:
dcM (t)
dt
=
γ(t)
Ω
(
cM−1 +
cM
M
)
+ p(M − 1)cM−1 + pcM − µ(N)McM , (12)
thus preserving the total cell count N . However, for Eq. 12 the truncation error shows up in
the total number of clonal types Ω =
∑M
k=0 ck, as the terms added to Eq. 12 to preserve
N artificially introduce new clonal types into the model. In contrast, Ω is preserved with the
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implementation of Eq. 11. IfM →∞, the truncation errors for both implementations go to zero
at ∼ 1/M , and the two implementations become equivalent. Assuming sufficiently large M ,
the truncation errors can be negligible in the context of γ(t) > 0, or have minimal cumulative
effects within a limited duration, such as a human lifetime, on which our investigations in this
paper have primarily focused.
In this paper, we adopt, for simplicity, Eq. 11 to numerically truncate Eq. 6. Note that this
choice may seem “natural” if one regards M as the carrying capacity, making it reasonable for
cM to have zero proliferation rate. However, the full mechanisms associated with the carrying
capacity are far more sophisticated than simply eliminating the proliferation of cM . Not only
should the proliferation rate of cM go to zero, the proliferation rate of the other ck should
also have a k dependence. The k dependence may be weak for small k, but as k → M , the
proliferation rate should attenuate significantly. The probability that ck→M will proliferate
should be very small, as it is highly likely that there exist other smaller clones to push the
total cell count up to the carrying capacity, prohibiting further proliferation. The k-dependent
proliferation rate will yield a natural truncation threshold at the carrying capacity. However,
such a sophisticated k-dependence of the proliferation rate is beyond the scope of this paper.
Our assumption here is simply that the truncation errors introduced by Eq. 11 are numerically
negligible and not biologically significant.
B Steady States of the Autonomous Equations
If we fix γ(t) = γ0, Eqs. 1, 6, and 11 become autonomous and admit the following steady state
solution,
css1 = γ0

γ0
Ω
M∑
i=1
1
i!µ(Nss)i−1

i−1∏
j=1
[γ0
Ω
+ jp
]+ µ(Nss)


−1
, (13)
cssk =
css1
k!µ(Nss)k−1
(
k−1∏
n=1
[γ0
Ω
+ np
])
, (14)
where Nss is the total population at steady state, given by the unique positive root of the
cubic,
c(N ; γ0) = (p0 − (µ0 + µ1))N
3 + γ0N
2 + (p0 − µ0)K
2N + γ0K
2. (15)
When γ0 = 0, c(N ; 0) has three real roots, N = 0, ±
√
((p − µ0)K2)/(µ0 + µ1 − p). The
positive steady state solution, which we denote by Nss(0), is stable, and the zero solution
unstable, under the parameter restrictions described in Section 2.1. We now demonstrate that
even though Eqs. 13, 14 indicate that each css
k
→ 0 as γ0 → 0, the quantity limM→∞
∑M
k=1 kc
ss
k
converges to a positive value qualitatively consistent with Nss(0) as γ0 → 0.
Proposition B: The steady state solutions css
k
, as given in Eqs. 13, 14, satisfy,
lim
γ0→0
lim
M→∞
M∑
k=1
kcssk > 0
Proof. We seek to derive upper and lower bounds, U(γ0), L(γ0), which satisfy,
L(γ0) ≤ lim
M→∞
M∑
k=1
kcssk ≤ U(γ0),
for γ0 > 0, and limγ0→0 U(γ0) ≥ limγ0→0 L(γ0) > 0. We first establish two small results,
which will be used later on:
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Proposition B1: For µ = µ(Nss(γ0)), limγ0→0
dµ
dγ0
> 0.
Proof. Recalling that µ = µ(Nss(γ0)) = µ0 + µ1(Nss(γ0)2/(Nss(γ0)2 +K2)), we have:
dµ
dγ0
=
dµ
dNss
dNss
dγ0
=
2µ1K2Nss
(N2ss +K
2)2
[
−(N2ss +K
2)
3(p0 − (µ0 + µ1))N2ss + 2γ0Nss + (p0 − µ0)K
2
]
=
−2µ1K2Nss
(N2ss +K
2) [3(p0 − (µ0 + µ1))N2ss + 2γ0Nss + (p0 − µ0)K
2]
where we computed the derivative dNss
dγ0
implicitly from the expression c(Nss(γ0); γ0) = 0.
From the explicit form Nss(0) =
√
(p0 − µ0)K2/((µ0 + µ1)− p0), we have:
lim
γ0−→0
dµ
dγ0
=
−2µ1K2NSS(0)
(NSS(0)2 +K2) [3(p0 − (µ0 + µ1))NSS(0)2 + (p0 − µ0)K2]
=
−2µ1K2NSS(0)
(NSS(0)2 +K2) [−2(p0 − µ0)K2]
> 0
Proposition B2: For f(p/µ(Nss(γ0)); γ0) =
γ0
pΩ
(
1− p
µ(Nss(γ0))
)−γ0
pΩ
−1
, limγ0→0 f(p/µ(Nss(γ0)); γ0) >
0.
Proof. We write the function f(p/µ(Nss(γ0)); γ0) as a product of two functions as follows:
f(p/µ(Nss(γ0)); γ0) =
γ0
pΩ
(
1−
p
µ(Nss(γ0))
)−γ0
pΩ
−1
=
(
1−
p
µ(Nss(γ0))
)−γ0
pΩ
·
γ0
pΩ
(
1−
p
µ(Nss(γ0))
)−1
= A(γ0) ·B(γ0)
We define A0 = limγ0→0A(γ0) and B0 = limγ0→0B(γ0), and compute A0 and B0:
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ln(A0) = lim
γ0−→0
−γ0
pΩ
ln
(
1−
p
µ(Nss(γ0))
)
=
−1
pΩ
lim
γ0−→0
ln
(
1− p
µ(Nss(γ0))
)
γ−10
=
−1
pΩ
lim
γ0−→0
(
1− p
µ(Nss(γ0))
)−1
d
dγ0
(
− p
µ(Nss(γ0))
)
−γ−20
=
1
pΩ
lim
γ0−→0
γ20
[
1−
p
µ(Nss(γ0))
]−1 [
pµ(Nss(γ0))
−2 dµ
dγ0
]
=
1
pΩ
lim
γ0−→0

 γ20p dµdγ0
µ(Nss(γ0))2 − pµ(Nss(γ0))


=
1
Ω
lim
γ0−→0

2γ0
dµ
dγ0
+ γ20
d2µ
dγ2
0
(2µ − p) dµ
dγ0


=
1
Ω

2γ0 limγ0→0
dµ
dγ0
+ γ20 limγ0→0
d2µ
dγ2
0
p limγ0→0
dµ
dγ0

 ,
where we used that µ(Nss(γ0))→ p as γ0 → 0. From Proposition B1, limγ0−→0
dµ
dγ0
> 0, and
a similar computation shows that limγ0→0
d2µ
dγ2
0
∈ R. Thus, ln(A0) ∈ R, and A0 > 0. Now,
B0 = lim
γ0→0
γ0
pΩ
(
1−
p
µ(Nss(γ0))
)−1
= lim
γ0→0
(γ0/pΩ)(
1− p
µ(Nss(γ0))
)
= lim
γ0→0
(1/pΩ)
pµ(Nss(γ0))−2
dµ
dγ0
= lim
γ0→0
µ(Nss(γ0))2
p2Ω dµ
dγ0
> 0.
Thus, limγ0→0
γ0
pΩ
(
1− p
µ(Nss)
)−γ0
pΩ
−1
= A0B0 > 0.
We now resume the proof of Proposition B. We first derive upper and lower bounds on the
term css1 , to simplify calculations. From the nonnegativity of the parameters and coefficient
functions, and the form in Eq. 13, css1 ≤ γ0/µ0, independent ofM . To derive anM -independent
lower bound on css1 , we observe that the sum in the denominator of Eq. 13 satisfies,
γ0
Ω
M∑
i=1
1
i!µ(Nss(γ0))i−1

i−1∏
j=1
[γ0
Ω
+ jp
] ≤ M∑
i=1
1
(i − 1)!µ(Nss(γ0))i−1

i−1∏
j=0
[γ0
Ω
+ jp
]
= p
M∑
i=1
1
(i− 1)!

i−1∏
j=0
[
γ0
pΩ
+ j
]( p
µ(Nss(γ0))
)i−1
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and that the sum on the right above is the M -th Taylor polynomial, SM,γ0 , for the function
f(x; γ0) =
γ0
pΩ
(1− x)
−γ0
pΩ
−1
expanded around x = 0 and evaluated at x = p
µ(Nss(γ0))
. The
function f(x; γ0) is analytic in x away from x = 1, and in particular, the SM,γ0 increase
monotonically to f(p/µ(Nss(γ0)); γ0). It follows that,
1
p
M∑
i=1
1
i!µ(Nss(γ0))i−1

i−1∏
j=0
[γ0
Ω
+ jp
] ≤ SM,γ0 ≤ f
(
p
µ(Nss(γ0))
; γ0
)
:= fγ0
and thus that css1 ≥ γ0/(pfγ0 + µ0 + µ1). After using the c
ss
1 bounds in the expression for c
ss
k
,
we have:
pΩ
pfγ0 + µ0 + µ1
SM,γ0 ≤
M∑
k=1
kcssk ≤
pΩ
µ0
SM,γ0
−→ lim
M→∞
pΩ
pfγ0 + µ0 + µ1
SM,γ0 ≤ lim
M→∞
M∑
k=1
kcssk ≤ lim
M→∞
pΩ
µ0
SM,γ0
−→
pΩ
pfγ0 + µ0 + µ1
fγ0 ≤ lim
M→∞
M∑
k=1
kcssk ≤
pΩ
µ0
fγ0
Now we let L(γ0) =
pΩ
pfγ0+µ0+µ1
fγ0 and U(γ0) =
pΩ
µ0
fγ0 . From Proposition B2, limγ0→0 fγ0 >
0, so limγ0→0 L(γ0), limγ0→0 U(γ0) > 0, and Proposition B follows.
C Convergence and Stability of ck when γ(t) → 0
In this section we will prove that solutions ck to our ODE system initialized sufficiently close to
−→
0 converge to
−→
0 as t→∞. Denote by (P) the “perturbed” ODE system given by Eqs. 6, 11,
with γ(t) = γ0e−at, and by (U) the “unperturbed” ODE system resulting from the alternate
choice γ(t) ≡ 0. For the sake of generality, we omit previous assumptions about the form of
the functions p(N), µ(N), except that p(0), µ(0) > 0. Additionally, in this section, we regard
the term N that appears in the ODEs as
∑
k≥1 kck instead of its own variable, and thus
do not explicitly include Eq. 1 in our analysis as in Appendix B. Note that the residual
N −
∑
k≥1 kck → 0 as M → ∞. We begin by noting that the unperturbed system (U) has
steady-state cU
k
(t) ≡ 0 for k ≥ 1. To analyze the stability of this steady state, we consider the
linearization of (U) around this steady state, which is represented by the M ×M matrix we
call LU (LU = (lij)1≤i,j≤M ). The components lij of LU are given explicitly by:
lij =


−j(p(0) + µ(0)), if i = j ≤M − 1
−Mµ(0), if i = j =M
jµ(0), if i = j − 1; 2 ≤ j ≤M
jp(0), if i = j + 1; 1 ≤ j ≤M − 1
0, otherwise


(16)
Although the matrix is tridiagonal, it is high-dimensional, and thus its eigenvalues cannot be
computed analytically. However, we may nevertheless demonstrate that all eigenvalues possess
strictly negative real part, indicating that the zero solution is asymptotically stable. To do this,
we use Gershgorin’s circle theorem to show that if there exists an eigenvalue λ ∈ C satisfying
ℜ(λ) ≥ 0, then λ = 0. We then verify that λ = 0 is never an eigenvalue of LU, by directly
demonstrating that LU has linearly independent rows.
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Proposition C: All eigenvalues λ ∈ C of the matrix LU satisfy ℜλ < 0, so that the zero-
solution of (U) is asymptotically stable.
We first apply Gershgorin’s circle theorem to the columns of the matrix LU to conclude
that all eigenvalues λ ∈ C of the truncated system (finiteM) are contained within the following
union of disks:
(
M−1⋃
i=1
{λ ∈ C : |λ+ i(p(0) + µ(0))| ≤ i(p(0) + µ(0))}
)⋃
{λ ∈ C : |λ+Mµ(0)| ≤Mµ(0)},
(17)
where we have used the fact that {λ ∈ C : |λ +D| ≤ D} ⊂ {λ ∈ C : |λ + (D + ǫ)| ≤ D + ǫ}
for D, ǫ > 0. Given the assumption that p(0), µ(0) > 0, each of these disks is tangent to the
line ℜλ = 0 at λ = 0, and otherwise lies entirely in the half plane ℜλ < 0. Thus, LU can only
possess an eigenvalue λ satisfying ℜλ = 0 if λ = 0 is itself an eigenvalue. We next verify that
λ = 0 is never an eigenvalue of LU directly, by establishing the linear independence of the
rows of LU.
Let us assume that there exist scalars a1, a2, . . . , aM , such that
∑M
j=1 aj (lij − 0) = 0 for
all 1 ≤ i ≤ M . Hence a normalized vector a = (a1, a2, . . . , aM ) represents the eigenvector
of the zero eigenvalue. For i = 1, we find that 2a2µ(0) − a1(p(0) + µ(0)) = 0, so that a2 =
2−1µ(0)−1(p(0) + µ(0))a1 . By moving on to larger i, we can recursively derive ai = Θia1
for all 2 ≤ i ≤ M with a proportional constant coefficient Θi. Moreover,
∑M
i=1
∑M
j=1 aj lij =
−a1µ(0) = 0, leading to a1 = 0 given that µ(0) > 0. If a1 = 0, a ≡ 0, and a non-zero eigenvector
does not exist, implying that zero is not among the eigenvalues of the M ×M matrix LU. We
thus conclude that all eigenvalues λ of the matrix LU satisfy ℜ(λ) < 0, and the zero-solution
of (U) is asymptotically stable for Eq. 6 truncated using Eq. 11 at an arbitrarily largeM . Note
that the proof in Eq. 17 does not hold if we use the alternative truncation formula Eq. 12. By
forcing all cells to remain below the truncation threshold M , it is not possible for all ck to
go to zero with a finite M . For the alternative truncation, the stable steady state solution is
ck = 2Nss/(M(M + 1)), which nevertheless goes to zero as M →∞.
We next proceed to demonstrate that the uniform asymptotic stability of the zero-solution
(cU
k
(t) ≡ 0 for k ≥ 1) of the unperturbed system (U) confers a similar notion of “stability”
on the perturbed system (P). In particular, the uniform asymptotic stability of the system
(U), in conjunction with the exponential decay of the function γ(t), implies that solutions of
the perturbed system (P) also converge to zero in magnitude, in a sense to be made more
precise later on. Here let us simplify our notation by writing (U) as dc/dt = f (c), where
c ≡ (c1, c2, . . . , cM ). The autonomous term f (c) consists of cell proliferation and death. Cor-
respondingly we express (P) as dc/dt = f (c)+g (t, c), where the nonautonomous term g (t, c)
describes thymic export that depends explicitly on the argument t. We appeal to results of
Strauss and Yorke in (1967), in particular their Theorem 4.6, which we may invoke to prove
that the solution of the perturbed system cP (t)→ 0 if the unperturbed and perturbed systems
(U) and (P) satisfy the following conditions:
1. The zero solution (cU (t) ≡ 0) of the unperturbed system (U) is uniformly asymptotically
stable.
2. The autonomous term f(c) is C1.
3. There exists r > 0 such that if |c| ≤ r, then |g(t, c)| ≤ η(t) for all t ≥ 0 where G(t) :=∫ t+1
t
η(s)ds → 0 as t→∞. (Here, we use the norm |c| =
∑M
i=1 |ci|.)
We now verify Conditions 1–3 above. Condition 1 follows immediately from the previous dis-
cussion, and the fact that for an autonomous system, asymptotic stability and uniform asymp-
totic stability are equivalent. Condition 2 is trivial. To verify Condition 3, we must construct
a suitable function η(t), using the definition of the function g(t, c):
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|g(t, c)| =
∣∣∣∣∣∣
γ0e−at
Ω

Ω − M∑
j=1
cj − c1


∣∣∣∣∣∣+
M−2∑
j=2
∣∣∣∣γ0e−atΩ (cj − cj+1)
∣∣∣∣+
∣∣∣∣γ0e−atΩ cM−1
∣∣∣∣ (18)
≤
γ0e−at
Ω
(
|Ω|+
(
M∑
i=1
|ci|
)
+ |c1|
)
+
M−2∑
j=2
γ0e−at
Ω
(|cj |+ |cj+1|) +
γ0e−at
Ω
|cM−1|
(19)
≤
γ0e−at
Ω
(
Ω + 3
M−1∑
i=1
|ci|
)
(20)
≤
γ0e−at
Ω
(Ω + 3|c|) (21)
= γ0e
−at
(
1 +
3
Ω
|c|
)
(22)
Thus, |g(t, c)| ≤ γ0e−at
(
1 + 3
Ω
|c|
)
, and for a given choice of r > 0, we may define ηr(t) :=
γ0e−at
(
1 + 3r
Ω
)
. From the exponential form of ηr(t), it is clear that limt→∞
∫ t+1
t
ηr(s)ds = 0.
Moreover, not only does there exist a single choice of r > 0 that produces a suitable ηr(t), but
any choice of r produces a suitable ηr(t).
From Theorem 4.6 in (Strauss and Yorke 1967), we may conclude that for any T0 ≥ 0,
there exists a δ0 > 0 such that if t0 ≥ T0 and |cP (t0)| ≤ δ0, then the solution of the perturbed
problem, cP (t), passing through (t0, cP (t0)) converges to zero in magnitude as t → ∞. Here
the proof of convergence holds for any sufficiently smooth function γ(t) → 0. Given Eq. 6
truncated at an arbitrarily large threshold M , all ck decline with the decaying thymic export
as t → ∞. While the total cell count is preserved by proliferation driving all cells above the
truncation threshold and out of the truncated system through truncation errors, the mean-field
approximation breaks down at the limit γ(t)/µ → 1/Ω ≪ 1, and Eq. 6 no longer accurately
describes the real biology. Nonetheless, our analysis here describes the decline of the number of
T-cell clones with decaying γ(t) as t→∞, before the mean-field approximation breaks down.
D Computation of Expected Sample Clonal Size Distribution
In this section, we detail the derivation of Eq. 10, the explicit expression for E[cY
k
]. We begin
with Eq. 9,
E[ck] =
R∑
j=1
jP
(
cYk = j
)
. (23)
Each term P
(
cY
k
= j
)
in Eq. 23 can itself be expanded as a sum over all the ways to choose
the j clones that are of size k. For a sample containing exactly Z clones of size k, we introduce
the following Z-tuple notation, for Z ∈ N:
IZ := {iZ = (i1, i2, . . . , iZ) : ij ∈ {1, 2, . . . , R}, ij < ij+1 for all j}. (24)
where iZ lists the indices of all the sample clones consisting of precisely k cells. Additionally, let
yi denote the size of the i-th ordered sample clone, so that yi1 = yi2 = · · · = yiZ = k, but no
other sample clone consists of k cells. Note that in iZ, clones are listed in numerical order, due
to the assumption ij < ij+1, in order to avoid repetition (e.g., in I2, (i1, i2) should be indistinct
from (i2, i1), and this pair should not be counted twice, as the significance is in which clone
numbers are listed at all, and not the order in which they are written.) With this, let P (iZ, k)
denote the probability that there are precisely Z clones of size k in the sample, and that their
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clone numbers are listed in the vector iZ. Additionally, for s ∈ N, denote by IZ,s ⊂ IZ the
collection of all iZ ∈ IZ such that iz∗ = s for some z
∗ ∈ {1, 2, · · · , Z}. Essentially, we are
imposing the assumption that the s-th clone specifically belongs somewhere in the list iZ,s.
Explicitly, we may write IZ,s as:
IZ,s = {iZ,s = (i1, . . . , iz∗−1, iz∗ = s, iz∗+1, . . . , iZ ) : ij ∈ {1, 2, . . . , R}, ij < ij+1 for all j }.
(25)
We define P (iZ,s, k) as the probability that there are precisely Z clones of size k, with clone
numbers listed in iZ,s, recalling that the s-th clone is in the list. We may further simplify Eq. 23
with this notation, rearranging sums by strategically regrouping clone size distributions that
share a common size k clone.
E[ck] =
R∑
j=1
jP (cYk = j), (26)
=
R∑
j=1
j

∑
ij∈Ij
P (ij, k)

 , (27)
=
R∑
s=1

 R∑
j=1
∑
ij,s∈Ij,s
P (ij,s, k)

 , (28)
=
R∑
s=1
P (ys = k), (29)
The terms of the final sum in Eq. 29 give the probability that the s-th clone is of size k,
independent of any other information about the sampling. This probability is easy to compute,
and given by:
P (ys = k) =
1(
N
Y
)(ns
k
)(N − ns
Y − k
)
. (30)
Inserting Eq. 30 into Eq. 29, we obtain a simple expression for the expected sample clone size
distribution:
E[ck] =
R∑
s=1
1(
N
Y
)(ns
k
)(N − ns
Y − k
)
. (31)
We can further simplify Eq. 31 by recognizing that the term
(
ns
k
)
is nonzero only if ns ≥ k.
We can thus rewrite Eq. 31 in terms of the true clone size distribution {cN
l
}R
l=1 as:
E[ck] =
R∑
l=k
1(
N
Y
) cNl ( lk
)(N − l
Y − k
)
. (32)
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